About US
Contact us
-
Drugmakers extend cut-price pneumonia vaccine deal(Reuters) - Pfizer and GlaxoSmithKline are increasing sales of cut-price pneumonia vaccine to developing countries by more than 50 percent, marking the scale-up of an international program to protect2011/12/20
-
GSK announces Huntington’s pact with University of DundeePharmaceutical major GlaxoSmithKline has signed a pact with the University of Dundee in the UKto investigate a potential treatment for Huntington's disease. The project will be based on the findings2011/12/20
-
Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal diseasePfizer Inc. (NYSE:PFE) today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company's commitment to help protect millions of infants and youn2011/12/19
-
Top drug shortages by treatment categoryby George Miller and Skye Toor Doctors, pharmacists and even the U.S. Congress use terms like "unprecedented," "crisis" and "significant risk" to describe current U.S. drug shortages. "We're gettin2011/12/16
-
Germany gives final OK to AstraZeneca heart drugDec 15 (Reuters) - AstraZeneca's big new drug hope Brilique has won a final recommendation from medical evaluation authorities in Germany, where it is the first medicine from any company to be assesse2011/12/16
-
Merck CEO defends hefty research spendingBy Lewis Krauskopf (Reuters) - The chief executive of Merck & Co (MRK.N) on Tuesday defended his refusal to slash the drugmaker's $8 billion research budget and warned that global price constrain2011/12/16
-
Big Pharma gets a driving lesson from carmakers(Reuters) - Big drugmakers, under pressure to streamline operations in the face of rising costs and slowing sales, are looking to the automotive industry for tips on tuning up their profit engines.2011/12/15
-
GSK subsidiary charged with fraudStiefel Laboratories, a subsidiary of GlaxoSmithKline, has been charged with fraud by the US Securities and Exchange Commission (SEC) after stock was repurchased at severely undervalued prices. It ha2011/12/15
-
GSK unit charged with fraud by US antitrust agencyThe US Securities and Exchange Commission has charged GlaxoSmithKline's Stiefel Laboratories subsidiary and its former chief executive with defrauding employees and other shareholders by buying back s2011/12/14
-
Pfizer Elects CEO Ian Read As Chairman Of The BoardTwo New Directors Elected to Pfizer Board - Marc Tessier-Lavigne, Ph.D. and Helen Hobbs, M.D. George Lorch Named Lead Independent Director NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today2011/12/14